FORM 10-C
Securities and Exchange Commission
Washington, DC 20549
REPORT BY ISSUER OF SECURITIES QUOTED ON THE NASDAQ STOCK MARKET,
FILED PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ECHANGE ACT OF 1934
AND RULE 13a-17 OR 15d-17 THEREUNDER.
Exact Name of Issuer as Specified in Charter: CONTOUR MEDICAL, INC.
Address of Principal Executive Offices: 3340 SCHERER DRIVE
ST. PETERSBURG, FLORIDA
Issuer's Telephone Number (Including Area Code): (813) 572-0089
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of five percent or more in the
number of shares outstanding:
1. Title of Security COMMON STOCK,
$.001 PAR VALUE
2. Number of Shares Outstanding Before
the Change 4,965,859
3. Number of Shares Outstanding After
the Change 5,214,223
4. Effective Date of Change MARCH 15, 1996
5. Method of Change STOCK SPLIT
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury, etc.)
Give brief description of transaction 1.05 FOR 1 STOCK SPLIT
II. CHANGE IN NAME OF ISSUER NOT APPLICABLE
1. Name prior to change
2. Name after change
3. Effective date of charter amendment
changing name
4. Date of shareholder approval of change,
if required
Date: March 20, 1996 /s/ Gerald J. Flanagan
Gerald J. Flanagan, President
(contour.9)
